Skip to content

Infinitus Partners with Cambridge to Establish Research Centre

Infinitus (China) Company Ltd., a health firm focused on traditional Chinese medicine, has signed a $6 million agreement with the University of Cambridge in England to establish the Cambridge Infinitus Research Centre (CIRCE).

Slated to open this fall, CIRCE will use state-of-the-art technology to explore the effects of plant-derived compounds, such as Infinitus’ herbal supplements, on cells and molecules. Cambridge’s Department of Chemical Engineering and Biotechnology building will house the new center.

The agreement also initiates a five-year academic partnership, intended to combine Infinitus’ research in Chinese herbal medicines with the university’s expertise in molecular cell biology. Cambridge academics will collaborate with the company’s research partners in China to integrate their findings into new health products.

“These kinds of partnerships are invaluable in helping our academics continue and expand their cutting-edge research,” Sir Leszek Borysiewicz, Vice-Chancellor of the University of Cambridge, said in a statement. “We are delighted that Infinitus has chosen to take their first step in international expansion at Cambridge.”

Infinitus, part of LKK Health Products Group (LKKHPG), has partnered with several top research organizations around the world to develop its nutrition, household and personal-care products. In 2014, the company generated annual revenue of $2.64 billion, placing it at No. 7 on the DSN Global 100 ranking of the industry’s top revenue-generating companies.

Infinitus’ latest partnership marks a new chapter in science and technology development for the company, according to LKKHPG Senior Vice President Tim Chun. “To work with the university and to benefit from the profound research strength in Cambridge provides Infinitus with great encouragement for the future,” he told the crowd at a signing ceremony held Sept. 2 at Cambridge.

Please follow and like us:
error

Leave a Comment

You must be logged in to post a comment.

Scroll To Top